Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by DryBoneson Mar 13, 2021 1:09am
88 Views
Post# 32791942

RE:diabetes patent awarded to LMNL...80B$ market

RE:diabetes patent awarded to LMNL...80B$ marketHow many patents do you suppose LMNL has already, 40, 50, 100? A lot for sure.  Has any led to a n FDA approval?  Have any led to a Health Canada approval (the home country)  has any led to an approval in Europe.  Welll not that I know of.  Perhaps you can enlighten the board dumbo.. I'm sure you will.  BTW what do the scum pay you for your reprrints of non-news?
<< Previous
Bullboard Posts
Next >>